A systematic review and meta-analysis of the R778L mutation in ATP7B with Wilson's disease in China
Ziru Xue,Hongyu Chen,Lan Yu,Peifang Jiang
DOI: https://doi.org/10.1016/j.pediatrneurol.2023.04.026
IF: 4.21
2023-05-10
Pediatric Neurology
Abstract:Background Wilson disease is a hereditary disorder of copper metabolism, caused by mutations in the ATP7B gene. Age of onset of WD varies and hepatic or neurologic presentations are the most common symptoms. There are more than 1,000 pathogenic variants identified in ATP7B . R778L is the most common ATP7B mutation in China. Methods To estimate whether R778L is associated with the onset age of WD and other clinical variables. Genotyping results of ATP7B gene were collected in our 22 patients with WD. We then conducted a systematic review and meta-analysis in Pubmed, EMBASE, Cochrane Library, Web of Science, and CNKI database, using the keywords Wilson disease and R778L mutation. Results After the screening, a total of 23 studies were included, including 3007 patients of WD. Patients with R778L mutation presented at an earlier age (SMD = -0.18 [95% Confidence Interval, -0.28 to 0.08], P=0.0004) and had lower levels of ceruloplasmin concentration (SMD= -0.21 [95% Confidence Interval, -0.40 to -0.02], P=0.03) than the patients without the R778L mutation. However, sex (OR= 1.07, [95% Confidence Interval, 0.89 to 1.29], P=0.32) and first presentation were not associated with R778L mutation in WD (hepatic: OR= 1.37, [95% Confidence Interval, 0.87 to 2.16, P=0.17; neurologic: OR= 0.79, [95% Confidence Interval, 0.48 to 1.30, P=0.35; mix: OR= 1.04, [95% Confidence Interval, 0.42 to 2.53, P=0.87; asymptomatic/others: OR= 1.98, [95% Confidence Interval, 0.49 to 7.96, P=0.34). Conclusions Our results indicated that the R778L mutation is associated with an earlier presentation and lower levels of ceruloplasmin concentration in China.
pediatrics,clinical neurology